SpyGlass Pharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SGP | YDES | OCUL | EYPT | ARDX | OCS | |
|---|---|---|---|---|---|---|
| Market cap | 831.52M | 448.36M | 1.66B | 278.35M | 833.95M | 485.31M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.8 | — | -5.1 | -1.2 | 11.1 | -4.1 |
| Price/book | 3.6 | 1.4 | 3.2 | 1.7 | 5.4 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −5.61% | −63.54% | −36.37% | −74.51% | −35.53% | −60.29% |
| Today | −0.24% | −5.94% | +0.27% | −2.35% | −1.52% | −5.52% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SGP news ›SpyGlass Pharma unveils positive 12-month data on BIM-IOL System
Interim 12-month safety and efficacy data on SpyGlass Pharma’s bimatoprost drug pad-intraocular lens system (BIM-IOL System) were presented over the weekend during the American Academy of Ophthalmology (AAO) annual meeting in New Orleans,…
SpyGlass Pharma to Participate in Upcoming Investor Conferences
IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate…
SpyGlass Pharma acquires Advanced Vision Science for $13M in cash
SpyGlass Pharma (SGP) announced the acquisition of all the outstanding shares of common stock of Advanced Vision Science for approximately $13M ... SpyGlass Pharma acquires Advanced Vision Science for $13M in cash SpyGlass Pharma (SGP)…
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
Under the agreement, AVS will be the exclusive manufacturer and supplier of several types of IOLs to Santen for commercialization in Japan. Additionally, AVS will continue to license its glistening-free hydrophobic acrylic lens material to…
Stifel Nicolaus Sticks to Its Buy Rating for SpyGlass Pharma (SGP)
Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on SpyGlass Pharma today and set a price target of $42.00. According to TipRanks, Stephan is a 4-star analyst with an average return of 10.4% and a 46.08% success rate. Stephan…
SpyGlass Pharma initiated with an Outperform at Raymond James
Raymond James analyst Christopher Raymond initiated coverage of SpyGlass Pharma (SGP) with an Outperform rating and $39 price target SpyGlass P... SpyGlass Pharma initiated with an Outperform at Raymond James Raymond James analyst…
Analysts Have Conflicting Sentiments on These NA Companies: Fiserv (FISV), SpyGlass Pharma (Nasdaq: SGP) and Evommune, Inc. (EVMN)
Analysts have been eager to weigh in on the NA sector with new ratings on Fiserv (FISV), SpyGlass Pharma (SGP) and Evommune, Inc. (EVMN). Wells Fargo analyst Jason Kupferberg maintained a Hold rating on Fiserv today and set a price target…
SpyGlass Pharma, Inc. : Insider Transactions
Follow insider transactions on SpyGlass Pharma, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions SpyGlass Pharma, Inc. Medical Equipment, Supplies & Distribution…
SpyGlass Pharma, Inc.: Official Announcements - Stock Market News
Find the latest press releases and official documents published by SpyGlass Pharma, Inc. on MarketScreener. Press Releases SpyGlass Pharma, Inc. Medical Equipment, Supplies & Distribution All financial news and data tailored to specific…
SpyGlass Pharma, Inc.: Latest Headlines - Nasdaq Stock Exchange
Find the latest highlights on SpyGlass Pharma, Inc. at the Nasdaq stock exchange. Highlights SpyGlass Pharma, Inc. Medical Equipment, Supplies & Distribution All financial news and data tailored to specific country editions
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com13
-
markets.businessinsider.com6
-
mobile.visionmonday.com2
-
visionmonday.com2
-
healio.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 35 articles, not a forecast.